Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation

Alzheimer's disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as amyloid pathology. We performed an exome-wide rare variant analysis of six AD biomarkers (β-amyloid, total/phosphorylated tau, NfL, YKL-4...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry Jg. 27; H. 4; S. 1990 - 1999
Hauptverfasser: Neumann, Alexander, Küçükali, Fahri, Bos, Isabelle, Vos, Stephanie J B, Engelborghs, Sebastiaan, De Pooter, Tim, Joris, Geert, De Rijk, Peter, De Roeck, Ellen, Tsolaki, Magda, Verhey, Frans, Martinez-Lage, Pablo, Tainta, Mikel, Frisoni, Giovanni, Blin, Oliver, Richardson, Jill, Bordet, Régis, Scheltens, Philip, Popp, Julius, Peyratout, Gwendoline, Johannsen, Peter, Frölich, Lutz, Vandenberghe, Rik, Freund-Levi, Yvonne, Streffer, Johannes, Lovestone, Simon, Legido-Quigley, Cristina, Ten Kate, Mara, Barkhof, Frederik, Strazisar, Mojca, Zetterberg, Henrik, Bertram, Lars, Visser, Pieter Jelle, van Broeckhoven, Christine, Sleegers, Kristel
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Nature Publishing Group 01.04.2022
Schlagworte:
ISSN:1359-4184, 1476-5578, 1476-5578
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Alzheimer's disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as amyloid pathology. We performed an exome-wide rare variant analysis of six AD biomarkers (β-amyloid, total/phosphorylated tau, NfL, YKL-40, and Neurogranin) to discover genes associated with these markers. Genetic and biomarker information was available for 480 participants from two studies: EMIF-AD and ADNI. We applied a principal component (PC) analysis to derive biomarkers combinations, which represent statistically independent biological processes. We then tested whether rare variants in 9576 protein-coding genes associate with these PCs using a Meta-SKAT test. We also tested whether the PCs are intermediary to gene effects on AD symptoms with a SMUT test. One PC loaded on NfL and YKL-40, indicators of neuronal injury and inflammation. Four genes were associated with this PC: IFFO1, DTNB, NLRC3, and SLC22A10. Mediation tests suggest, that these genes also affect dementia symptoms via inflammation/injury. We also observed an association between a PC loading on Neurogranin, a marker for synaptic functioning, with GABBR2 and CASZ1, but no mediation effects. The results suggest that rare variants in IFFO1, DTNB, NLRC3, and SLC22A10 heighten susceptibility to neuronal injury and inflammation, potentially by altering cytoskeleton structure and immune activity disinhibition, resulting in an elevated dementia risk. GABBR2 and CASZ1 were associated with synaptic functioning, but mediation analyses suggest that the effect of these two genes on synaptic functioning is not consequential for AD development.
AbstractList Alzheimer's disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as amyloid pathology. We performed an exome-wide rare variant analysis of six AD biomarkers (β-amyloid, total/phosphorylated tau, NfL, YKL-40, and Neurogranin) to discover genes associated with these markers. Genetic and biomarker information was available for 480 participants from two studies: EMIF-AD and ADNI. We applied a principal component (PC) analysis to derive biomarkers combinations, which represent statistically independent biological processes. We then tested whether rare variants in 9576 protein-coding genes associate with these PCs using a Meta-SKAT test. We also tested whether the PCs are intermediary to gene effects on AD symptoms with a SMUT test. One PC loaded on NfL and YKL-40, indicators of neuronal injury and inflammation. Four genes were associated with this PC: IFFO1, DTNB, NLRC3, and SLC22A10. Mediation tests suggest, that these genes also affect dementia symptoms via inflammation/injury. We also observed an association between a PC loading on Neurogranin, a marker for synaptic functioning, with GABBR2 and CASZ1, but no mediation effects. The results suggest that rare variants in IFFO1, DTNB, NLRC3, and SLC22A10 heighten susceptibility to neuronal injury and inflammation, potentially by altering cytoskeleton structure and immune activity disinhibition, resulting in an elevated dementia risk. GABBR2 and CASZ1 were associated with synaptic functioning, but mediation analyses suggest that the effect of these two genes on synaptic functioning is not consequential for AD development.Alzheimer's disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as amyloid pathology. We performed an exome-wide rare variant analysis of six AD biomarkers (β-amyloid, total/phosphorylated tau, NfL, YKL-40, and Neurogranin) to discover genes associated with these markers. Genetic and biomarker information was available for 480 participants from two studies: EMIF-AD and ADNI. We applied a principal component (PC) analysis to derive biomarkers combinations, which represent statistically independent biological processes. We then tested whether rare variants in 9576 protein-coding genes associate with these PCs using a Meta-SKAT test. We also tested whether the PCs are intermediary to gene effects on AD symptoms with a SMUT test. One PC loaded on NfL and YKL-40, indicators of neuronal injury and inflammation. Four genes were associated with this PC: IFFO1, DTNB, NLRC3, and SLC22A10. Mediation tests suggest, that these genes also affect dementia symptoms via inflammation/injury. We also observed an association between a PC loading on Neurogranin, a marker for synaptic functioning, with GABBR2 and CASZ1, but no mediation effects. The results suggest that rare variants in IFFO1, DTNB, NLRC3, and SLC22A10 heighten susceptibility to neuronal injury and inflammation, potentially by altering cytoskeleton structure and immune activity disinhibition, resulting in an elevated dementia risk. GABBR2 and CASZ1 were associated with synaptic functioning, but mediation analyses suggest that the effect of these two genes on synaptic functioning is not consequential for AD development.
Alzheimer's disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as amyloid pathology. We performed an exome-wide rare variant analysis of six AD biomarkers (β-amyloid, total/phosphorylated tau, NfL, YKL-40, and Neurogranin) to discover genes associated with these markers. Genetic and biomarker information was available for 480 participants from two studies: EMIF-AD and ADNI. We applied a principal component (PC) analysis to derive biomarkers combinations, which represent statistically independent biological processes. We then tested whether rare variants in 9576 protein-coding genes associate with these PCs using a Meta-SKAT test. We also tested whether the PCs are intermediary to gene effects on AD symptoms with a SMUT test. One PC loaded on NfL and YKL-40, indicators of neuronal injury and inflammation. Four genes were associated with this PC: IFFO1, DTNB, NLRC3, and SLC22A10. Mediation tests suggest, that these genes also affect dementia symptoms via inflammation/injury. We also observed an association between a PC loading on Neurogranin, a marker for synaptic functioning, with GABBR2 and CASZ1, but no mediation effects. The results suggest that rare variants in IFFO1, DTNB, NLRC3, and SLC22A10 heighten susceptibility to neuronal injury and inflammation, potentially by altering cytoskeleton structure and immune activity disinhibition, resulting in an elevated dementia risk. GABBR2 and CASZ1 were associated with synaptic functioning, but mediation analyses suggest that the effect of these two genes on synaptic functioning is not consequential for AD development.
Author van Broeckhoven, Christine
Streffer, Johannes
Engelborghs, Sebastiaan
Frisoni, Giovanni
Peyratout, Gwendoline
De Rijk, Peter
Joris, Geert
Legido-Quigley, Cristina
Bos, Isabelle
Johannsen, Peter
Frölich, Lutz
De Pooter, Tim
Tsolaki, Magda
Barkhof, Frederik
Verhey, Frans
Bordet, Régis
Blin, Oliver
Zetterberg, Henrik
Bertram, Lars
Strazisar, Mojca
Sleegers, Kristel
Vos, Stephanie J B
Ten Kate, Mara
Freund-Levi, Yvonne
Visser, Pieter Jelle
Küçükali, Fahri
Richardson, Jill
Neumann, Alexander
Tainta, Mikel
De Roeck, Ellen
Martinez-Lage, Pablo
Popp, Julius
Vandenberghe, Rik
Lovestone, Simon
Scheltens, Philip
Author_xml – sequence: 1
  givenname: Alexander
  orcidid: 0000-0001-6653-3203
  surname: Neumann
  fullname: Neumann, Alexander
  email: alexander.neumann@uantwerpen.vib.be, alexander.neumann@uantwerpen.vib.be
  organization: Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. alexander.neumann@uantwerpen.vib.be
– sequence: 2
  givenname: Fahri
  orcidid: 0000-0002-3835-9639
  surname: Küçükali
  fullname: Küçükali, Fahri
  organization: Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
– sequence: 3
  givenname: Isabelle
  surname: Bos
  fullname: Bos, Isabelle
  organization: Netherlands Institute for Health Services Research, Utrecht, the Netherlands
– sequence: 4
  givenname: Stephanie J B
  surname: Vos
  fullname: Vos, Stephanie J B
  organization: Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands
– sequence: 5
  givenname: Sebastiaan
  orcidid: 0000-0003-0304-9785
  surname: Engelborghs
  fullname: Engelborghs, Sebastiaan
  organization: Department of Neurology and Memory Clinic, Universitair Ziekenhuis Brussel (UZ Brussel) and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium
– sequence: 6
  givenname: Tim
  surname: De Pooter
  fullname: De Pooter, Tim
  organization: Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
– sequence: 7
  givenname: Geert
  surname: Joris
  fullname: Joris, Geert
  organization: Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
– sequence: 8
  givenname: Peter
  surname: De Rijk
  fullname: De Rijk, Peter
  organization: Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
– sequence: 9
  givenname: Ellen
  surname: De Roeck
  fullname: De Roeck, Ellen
  organization: Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium
– sequence: 10
  givenname: Magda
  orcidid: 0000-0002-2072-8010
  surname: Tsolaki
  fullname: Tsolaki, Magda
  organization: 1st Department of Neurology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Thessaloniki, Greece
– sequence: 11
  givenname: Frans
  surname: Verhey
  fullname: Verhey, Frans
  organization: School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands
– sequence: 12
  givenname: Pablo
  surname: Martinez-Lage
  fullname: Martinez-Lage, Pablo
  organization: Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain
– sequence: 13
  givenname: Mikel
  surname: Tainta
  fullname: Tainta, Mikel
  organization: Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain
– sequence: 14
  givenname: Giovanni
  orcidid: 0000-0001-7075-7082
  surname: Frisoni
  fullname: Frisoni, Giovanni
  organization: RCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
– sequence: 15
  givenname: Oliver
  surname: Blin
  fullname: Blin, Oliver
  organization: Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital, Marseille, France
– sequence: 16
  givenname: Jill
  surname: Richardson
  fullname: Richardson, Jill
  organization: Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevanage, UK
– sequence: 17
  givenname: Régis
  surname: Bordet
  fullname: Bordet, Régis
  organization: Neuroscience & Cognition, CHU de Lille, University of Lille, Inserm, France
– sequence: 18
  givenname: Philip
  orcidid: 0000-0002-1046-6408
  surname: Scheltens
  fullname: Scheltens, Philip
  organization: Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands
– sequence: 19
  givenname: Julius
  surname: Popp
  fullname: Popp, Julius
  organization: Old Age Psychiatry, Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland
– sequence: 20
  givenname: Gwendoline
  surname: Peyratout
  fullname: Peyratout, Gwendoline
  organization: Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland
– sequence: 21
  givenname: Peter
  surname: Johannsen
  fullname: Johannsen, Peter
  organization: Clinical Drug Development, Novo Nordisk, Copenhagen, Denmark
– sequence: 22
  givenname: Lutz
  orcidid: 0000-0003-1494-0813
  surname: Frölich
  fullname: Frölich, Lutz
  organization: Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
– sequence: 23
  givenname: Rik
  surname: Vandenberghe
  fullname: Vandenberghe, Rik
  organization: Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
– sequence: 24
  givenname: Yvonne
  orcidid: 0000-0001-6863-6679
  surname: Freund-Levi
  fullname: Freund-Levi, Yvonne
  organization: School of Medical Sciences Örebro, University Örebro, Örebro, Sweden
– sequence: 25
  givenname: Johannes
  surname: Streffer
  fullname: Streffer, Johannes
  organization: Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
– sequence: 26
  givenname: Simon
  surname: Lovestone
  fullname: Lovestone, Simon
  organization: Janssen Medical Ltd, High Wycombe, UK
– sequence: 27
  givenname: Cristina
  surname: Legido-Quigley
  fullname: Legido-Quigley, Cristina
  organization: Institute of Pharmaceutical Sciences, King's College London, London, UK
– sequence: 28
  givenname: Mara
  surname: Ten Kate
  fullname: Ten Kate, Mara
  organization: Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands
– sequence: 29
  givenname: Frederik
  surname: Barkhof
  fullname: Barkhof, Frederik
  organization: Institutes of Neurology and Healthcare Engineering, University College London, London, UK
– sequence: 30
  givenname: Mojca
  surname: Strazisar
  fullname: Strazisar, Mojca
  organization: Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
– sequence: 31
  givenname: Henrik
  orcidid: 0000-0003-3930-4354
  surname: Zetterberg
  fullname: Zetterberg, Henrik
  organization: Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
– sequence: 32
  givenname: Lars
  orcidid: 0000-0002-0108-124X
  surname: Bertram
  fullname: Bertram, Lars
  organization: Centre for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway
– sequence: 33
  givenname: Pieter Jelle
  surname: Visser
  fullname: Visser, Pieter Jelle
  organization: Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands
– sequence: 34
  givenname: Christine
  orcidid: 0000-0003-0183-7665
  surname: van Broeckhoven
  fullname: van Broeckhoven, Christine
  organization: Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
– sequence: 35
  givenname: Kristel
  orcidid: 0000-0002-0283-2332
  surname: Sleegers
  fullname: Sleegers, Kristel
  organization: Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35173266$$D View this record in MEDLINE/PubMed
BookMark eNpdkE1P3DAQhi0E4qv9AxyQpR7ogbRjO_7IcQndstIKJNieV5PE1nqVONROQMu1f7yh3V56mtG8jx7NzBk5DH2whFww-MJAmK8pZ8JABpxnwHKhM3VATlmuVSalNodTL2SR5czkJ-QspS3AeyiPyYmQTAuu1Cn59YjR0heMHsOQqA90MZ8_sGt6u7q_uab3y8dSUAwNfVqWnM8YUEyprz0Olr76YUNn7dvG-s7Gq0QbnywmS8unOX2OvfOtpb2jwY6xD9hO9u0Yd390PrgWuw4H34cP5Mhhm-zHfT0nP-bfVuVdtnz4vihny6yWRg9ZDVgAABe6ymtEJw00lVHgdFPYqmKiMhxyiUXToMYJzgUaKaaZc9y6SpyTz3-9024_R5uGdedTbdsWg-3HtOaKF0YZUGxCP_2HbvsxTje8U0oXsmAKJupyT41VZ5v1c_Qdxt3633vFb8xefCc
CitedBy_id crossref_primary_10_1186_s40035_024_00397_x
crossref_primary_10_1002_advs_202407628
crossref_primary_10_1177_13872877251337944
crossref_primary_10_3390_biomedicines11072079
crossref_primary_10_1002_hbm_26641
crossref_primary_10_1002_alz_13449
crossref_primary_10_1016_j_immuni_2024_03_010
crossref_primary_10_1007_s00018_022_04614_6
crossref_primary_10_1016_j_jnutbio_2024_109790
crossref_primary_10_1038_s41582_025_01062_1
crossref_primary_10_3389_fimmu_2022_1012459
crossref_primary_10_1177_25424823251328300
crossref_primary_10_3390_biomedicines10081772
crossref_primary_10_1111_acel_14403
ContentType Journal Article
Contributor van Broeckhoven, Christine
Streffer, Johannes
Engelborghs, Sebastiaan
Frisoni, Giovanni
Peyratout, Gwendoline
Legido-Quigley, Cristina
Bos, Isabelle
Johannsen, Peter
Frölich, Lutz
Tsolaki, Magda
Barkhof, Frederik
Verhey, Frans
Bordet, Régis
Blin, Oliver
Zetterberg, Henrik
Bertram, Lars
Sleegers, Kristel
Vos, Stephanie J B
Ten Kate, Mara
Freund-Levi, Yvonne
Visser, Pieter Jelle
Küçükali, Fahri
Richardson, Jill
Neumann, Alexander
Tainta, Mikel
De Roeck, Ellen
Martinez-Lage, Pablo
Popp, Julius
Vandenberghe, Rik
Lovestone, Simon
Scheltens, Philip
Contributor_xml – sequence: 1
  givenname: Alexander
  surname: Neumann
  fullname: Neumann, Alexander
– sequence: 2
  givenname: Fahri
  surname: Küçükali
  fullname: Küçükali, Fahri
– sequence: 3
  givenname: Isabelle
  surname: Bos
  fullname: Bos, Isabelle
– sequence: 4
  givenname: Stephanie J B
  surname: Vos
  fullname: Vos, Stephanie J B
– sequence: 5
  givenname: Sebastiaan
  surname: Engelborghs
  fullname: Engelborghs, Sebastiaan
– sequence: 6
  givenname: Ellen
  surname: De Roeck
  fullname: De Roeck, Ellen
– sequence: 7
  givenname: Magda
  surname: Tsolaki
  fullname: Tsolaki, Magda
– sequence: 8
  givenname: Frans
  surname: Verhey
  fullname: Verhey, Frans
– sequence: 9
  givenname: Pablo
  surname: Martinez-Lage
  fullname: Martinez-Lage, Pablo
– sequence: 10
  givenname: Mikel
  surname: Tainta
  fullname: Tainta, Mikel
– sequence: 11
  givenname: Giovanni
  surname: Frisoni
  fullname: Frisoni, Giovanni
– sequence: 12
  givenname: Oliver
  surname: Blin
  fullname: Blin, Oliver
– sequence: 13
  givenname: Jill
  surname: Richardson
  fullname: Richardson, Jill
– sequence: 14
  givenname: Régis
  surname: Bordet
  fullname: Bordet, Régis
– sequence: 15
  givenname: Philip
  surname: Scheltens
  fullname: Scheltens, Philip
– sequence: 16
  givenname: Julius
  surname: Popp
  fullname: Popp, Julius
– sequence: 17
  givenname: Gwendoline
  surname: Peyratout
  fullname: Peyratout, Gwendoline
– sequence: 18
  givenname: Peter
  surname: Johannsen
  fullname: Johannsen, Peter
– sequence: 19
  givenname: Lutz
  surname: Frölich
  fullname: Frölich, Lutz
– sequence: 20
  givenname: Rik
  surname: Vandenberghe
  fullname: Vandenberghe, Rik
– sequence: 21
  givenname: Yvonne
  surname: Freund-Levi
  fullname: Freund-Levi, Yvonne
– sequence: 22
  givenname: Johannes
  surname: Streffer
  fullname: Streffer, Johannes
– sequence: 23
  givenname: Simon
  surname: Lovestone
  fullname: Lovestone, Simon
– sequence: 24
  givenname: Cristina
  surname: Legido-Quigley
  fullname: Legido-Quigley, Cristina
– sequence: 25
  givenname: Mara
  surname: Ten Kate
  fullname: Ten Kate, Mara
– sequence: 26
  givenname: Frederik
  surname: Barkhof
  fullname: Barkhof, Frederik
– sequence: 27
  givenname: Henrik
  surname: Zetterberg
  fullname: Zetterberg, Henrik
– sequence: 28
  givenname: Lars
  surname: Bertram
  fullname: Bertram, Lars
– sequence: 29
  givenname: Pieter Jelle
  surname: Visser
  fullname: Visser, Pieter Jelle
– sequence: 30
  givenname: Christine
  surname: van Broeckhoven
  fullname: van Broeckhoven, Christine
– sequence: 31
  givenname: Kristel
  surname: Sleegers
  fullname: Sleegers, Kristel
Copyright 2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor EMIF-AD study group
CorporateAuthor_xml – name: EMIF-AD study group
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1038/s41380-022-01437-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1476-5578
EndPage 1999
ExternalDocumentID 35173266
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GroupedDBID ---
-Q-
0R~
123
29M
2WC
36B
39C
4.4
406
53G
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYZH
ABAKF
ABAWZ
ABDBE
ABDBF
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AXYYD
AYFIA
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CUY
CVF
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
ECM
EE.
EIF
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
IPY
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
NPM
NQJWS
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UKHRP
~8M
3V.
7TK
7XB
8FE
8FH
8FK
ABBRH
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
K9.
LK8
PHGZM
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c587t-c0a9000237b4caaf580db860f7d9ebb13b82045a9dda7a0a943a853204ff2efb3
IEDL.DBID M7P
ISICitedReferencesCount 18
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000756220100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1359-4184
1476-5578
IngestDate Thu Nov 20 07:28:52 EST 2025
Tue Oct 07 06:09:30 EDT 2025
Thu Apr 03 07:01:05 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License 2022. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c587t-c0a9000237b4caaf580db860f7d9ebb13b82045a9dda7a0a943a853204ff2efb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0183-7665
0000-0001-6653-3203
0000-0003-1494-0813
0000-0003-3930-4354
0000-0002-0108-124X
0000-0001-6863-6679
0000-0002-2072-8010
0000-0002-3835-9639
0000-0003-0304-9785
0000-0002-1046-6408
0000-0001-7075-7082
0000-0002-0283-2332
OpenAccessLink https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-97581
PMID 35173266
PQID 2667959160
PQPubID 44096
PageCount 10
ParticipantIDs proquest_miscellaneous_2629868061
proquest_journals_2667959160
pubmed_primary_35173266
PublicationCentury 2000
PublicationDate 2022-04-01
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Molecular psychiatry
PublicationTitleAlternate Mol Psychiatry
PublicationYear 2022
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
SSID ssj0014765
Score 2.472646
Snippet Alzheimer's disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as...
Alzheimer’s disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1990
SubjectTerms Alzheimer Disease - diagnosis
Alzheimer's disease
Amyloid beta-Peptides - genetics
Biomarkers
Cerebrospinal fluid
Chitinase-3-Like Protein 1 - genetics
Cytoskeleton
Dementia
Dementia disorders
Dithionitrobenzoic Acid
DNA-Binding Proteins
Humans
Inflammation
Inflammation - genetics
Intercellular Signaling Peptides and Proteins
Neural coding
Neurodegenerative diseases
Neurogranin
Neurogranin - genetics
Tau protein
tau Proteins
Transcription Factors
β-Amyloid
Title Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation
URI https://www.ncbi.nlm.nih.gov/pubmed/35173266
https://www.proquest.com/docview/2667959160
https://www.proquest.com/docview/2629868061
Volume 27
WOSCitedRecordID wos000756220100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbhMxFLVoCxIb3o9AiYzEslY99szYXqE0dARSMkRpkbKLbM-1GgSTkkkrwYoNH8Hv8SXYHresYMPGkjWWZfk-fMf3-hyEXrECmAHqDanMLcn9GUkUNIIYxx0Iy2xpI87sRNS1XCzULF24dams8sonRkfdrG24Iz_0B0mgxc5K-vr8CwmsUSG7mig0dtBeQElgsXRvdp1FyEWkksx4EbKdMk-PZiiXh5133pKSUMseEO4EKf8eYsajprr7v4u8h-6kIBOPeq24j25A-wDd6mknvz5EP-Z6A_jS_yWHIhi8avG7qnqfHeA3p_XRAa4n8zHHum3wyWTM2CijWCchAg73tnj06dsZrD7D5tf3nx1OOR48PqlwogDHa4cjUmZYxqr96AUXJ_Tq7DWwfy35CH2ojk_Hb0miYyC2kGJLLNUq4uMIk1utXSFpY2RJnWgUGJNxIwO2vVZNo4X2g3OuZeCdyJ1j4Ax_jHbbdQtPEWbOgOba6oZCXjBQXDurmAQfb6pM8wHav9rfZbKpbvlncwfo5fVnbw0hxaFbWF-EMUzJUvogZYCe9DJcnvewHUteZMIHq-Wzf0_-HN1mUS1Cdc4-2t1uLuAFumkvt6tuM0Q7YiFiK4do7-i4ns19b8qmw6h6vq1n09-btt3q
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qBVQ2vB8DBYwEu0ZNbCd2FggNU6KOmgbUDlJ3qe1cq4MgUybTorJiw0fwE3wUX4KdZMoKdl2wjmVZvuc-4vs4AM9pjFRj6BQp4SbgzkcGKVYi0JZZFIaaxLRzZnNRFPLgIH23Aj-XvTC-rHJpE1tDXc2MfyPfdI7E02JHSfjq-HPgWaN8dnVJodHBYgfPvrhftubleMvJ9wWl2ZvJaDvoWQUCE0uxCEyo0nbMi9DcKGVjGVZaJqEVVYpaR0xLP6JdpVWlhHKLOVPS0ydwaylazdy-l-Ay9y2jvlSQ7p5nLbhoqSsjFvvsquR9k07I5GbjnIUMA1877yfqiSD5e0jburbsxv92KTfheh9Ek2GH-luwgvVtuNrRap7dge97ao7kVDndqhcNmdZknGVvow2yNSleb5Ai3xsxouqK7OcjSodRSFQPUiT-XZoMP349wuknnP_69qMhfQ6LjPYz0lOck5kl7SRQf4xp_cEBs93QqavTsK4b9C68v5A7uAer9azGB0Co1aiYMqoKkccUU6asSalEF0-nkWIDWF_Ks-xtRlP-EeYAnp1_dtruUziqxtmJX0NTmUgXhA3gfoeZ8rgbS1KyOBIuGE8e_nvzp7C2PdnNy3xc7DyCa7SFpK9EWofVxfwEH8MVc7qYNvMnLbgJHF40cH4D1tM2lA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9MwGH41OkC78A0rDDAS3BbVsZPYOSDUtYuoVoWqG9JuwXFea51YujXd0Dhx4UfwV_g5_BLsJB0nuO3AOZZl-X3ej_j9eABesxBZjtQqUhRoL7A-0ouxEF5uuEGhmY50PWd2LNJUHh7GkzX4ueqFcWWVK5tYG-pirt0bec86EkeL7Ue0Z9qyiMkweXd65jkGKZdpXdFpNBDZw8sv9vetejsaWlm_YSzZPRi891qGAU-HUiw9TVVcj3wReaCVMqGkRS4jakQRY577PJduXLuKi0IJZRcHXElHpRAYw9Dk3O57A9aFDTKCDqzv7KaT6VUOIxA1kaXPQ5drlUHbskO57FXWdUjquUp6N19PeNHfA9za0SV3_-crugd32vCa9Bt9uA9rWD6AWw3h5uVD-D5VCyQXympduazIrCSjJPngb5PhQbqzTdLxdMCJKguyPx4w1vcpUS18kbgXa9L__PUIZye4-PXtR0Xa7BYZ7CekJT8nc0PqGaHuGLPy2EK23tAqstW9pk_0EXy8ljt4DJ1yXuImEGZyVFxpVVAMQoYxV0bHTKKNtGNf8S5srWSbtdakyv4Itguvrj5bO-CSO6rE-blbw2IZSRuedeFJg5_stBlYkvHQFzZMj57-e_OXcNviJRuP0r1nsMFqdLoSpS3oLBfn-Bxu6ovlrFq8aJFO4NN1I-c3UfdArg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rare+variants+in+IFFO1%2C+DTNB%2C+NLRC3+and+SLC22A10+associate+with+Alzheimer%E2%80%99s+disease+CSF+profile+of+neuronal+injury+and+inflammation&rft.jtitle=Molecular+psychiatry&rft.au=Neumann%2C+Alexander&rft.au=K%C3%BC%C3%A7%C3%BCkali+Fahri&rft.au=Bos%2C+Isabelle&rft.au=Vos+Stephanie+J+B&rft.date=2022-04-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.eissn=1476-5578&rft.volume=27&rft.issue=4&rft.spage=1990&rft.epage=1999&rft_id=info:doi/10.1038%2Fs41380-022-01437-6&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon